It has been demonstrated that the dysregulation of BAP1 and its associated factors are involved in the tumorigenesis of many different cancer types, including uveal melanoma (26), breast cancer (27, 28), prostate cancer (29, 30), leukemia (19, 21), and lung cancer (31, 32). This evidence concerns the gene BAP1 and prostate cancer.